Epoetin alpha every 2 weeks vs to weekly
Adverse events: hypertension · anaemia in predialysis patients
Epoetin alpha every 2 weeks showed no clear difference in adverse events: hypertension compared with to weekly (moderate certainty).
1 finding from 1 review
- Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients 2017 · Cochrane Headline outcomes onlyRR 0.85 [0.55, 1.32]4 studies · 838 participantsModerate